IPS HEART
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

  • Home
  • About Us
  • Our Approach
  • Our Pipeline
  • Why Heart Disease?
  • Why DMD?
  • Platform
  • Publications
  • Clinical Efficacy
  • More
    • Home
    • About Us
    • Our Approach
    • Our Pipeline
    • Why Heart Disease?
    • Why DMD?
    • Platform
    • Publications
    • Clinical Efficacy
IPS HEART

Signed in as:

filler@godaddy.com

  • Home
  • About Us
  • Our Approach
  • Our Pipeline
  • Why Heart Disease?
  • Why DMD?
  • Platform
  • Publications
  • Clinical Efficacy

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

WHY HEART DISEASE?

Heart disease is the leading cause of death globally.


It kills more annually than all forms of cancer combined.

Current heart attack therapeutics only address symptoms and cannot restore heart function.

  • Over 1 Million heart attacks in the U.S. each year


  • 659,000 deaths per year killing more annually than all forms of cancer combined


  • One billion heart cells are lost after a heart attack


  • There has been no way to regenerate new heart tissue as all current drugs only provide symptomatic relief


  • Congestive Heart Failure Drugs alone are forecasted to reach $18.1 billion by 2027 with the heart failure device market projected to reach $20.5 billion by 2030

  

Future therapies will reverse damage caused following a heart attack

Copyright © 2014 IPS HEART - All Rights Reserved.